CareRx Corp is seeing a significant rise in its stock price, reflecting positive investor sentiment.
Shares of CareRx Corp (CRRX.TO) are up 3.38% today, closing at CA$3.67. This increase follows solid financial performance and strategic growth initiatives.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
CareRx Corp
CRRX.TO
CRRX.TO
CareRx Corp
WealthAwesomeMarket cap
$216.99M
P/E
8.0x
Div. yield
1.75%
Div. / share
$0.06
52W high
$3.95
52W low
$2.64
1W change
+6.29%
Beta
0.60
Analyst Price Targets
Based on analyst covering CRRX
Wall Street analysts forecast CRRX stock price to rise 44.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.14
+44.9% Upside
Current Price
C$3.55
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRRX's historical volatility
30-Day Vol
22.0%
Annualized
90-Day Vol
25.8%
Annualized
Trend (90d)
-12.8%
Annualized drift
90d Mean
C$3.39
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$3.50 | C$3.24 – C$3.77 |
| 60 trading days | C$3.44 | C$3.09 – C$3.83 |
| 90 trading days | C$3.39 | C$2.97 – C$3.87 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: The recent uptick in CareRx's stock price indicates that investors are optimistic about the company's financial health and growth potential, making it a stock to keep an eye on in the healthcare sector.
CareRx Corp's stock jumps 3.38% today
CareRx's market capitalization is now CA$216.99 million, showcasing a strong position in the healthcare sector.
Bull case
With a P/E ratio of 8.26, CareRx seems undervalued compared to its industry peers. This presents a potential entry point for investors seeking growth in the healthcare market.
Bear case
Even with today's gains, investors should keep in mind that CareRx does not offer a dividend yield and market volatility could affect future performance.
Financial Performance Highlights
Advertisement
CareRx recently reported strong financial results, showing increased adjusted EBITDA and a reduction in net debt. These metrics contribute to a positive outlook for the company, drawing investor interest.
Market Position and Valuation
With a market cap of CA$216.99 million and a P/E ratio of 8.26, CareRx stands out as an appealing investment opportunity in the healthcare sector. Its valuation suggests room for growth, especially as demand for healthcare services continues to rise.
Looking Ahead
As CareRx navigates the changing healthcare landscape, investors will be eager to watch upcoming earnings reports and any strategic initiatives that could further strengthen the company's market position.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
